Drug Database
Back to search

Germany· DE-A57-706e8c43b827f1c1

Dihydrocodein Aristo

A dihydrocodeine product containing dihydrocodeine, registered in Germany by Aristo Pharma Gmbh (Art 57). The same ATC class is registered in 9 of our 19 countries.

ATC N02AA08

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedDihydrocodein AristoATCN02AA08REGISTER NO.DE-A57-706e8c43b827f1…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dihydrocodeineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dihydrocodeine is registered in 9 of 19 countries.

Countries holding a registration under ATC N02AA08 (dihydrocodeine), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 5 of them publish a price we can compare per daily dose
Search dihydrocodeine products by name

Dihydrocodeine · ATC N02AA08

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Germany
  • Ireland
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Dihydrocodeine
Manufacturer
Aristo Pharma Gmbh (Art 57)
Country
Germany (DE)
ATC code
N02AA08
ATC class
Dihydrocodeine
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

165 interactions on record for dihydrocodeine.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dihydrocodeine against other medicinesHow interaction checks work

Dihydrocodeine · interactions on record

165 records

  • 16 severe
  • 147 moderate

Most severe, free to view

  • AlvimopanA06AH02severe
  • ChlorphenesinD01AE07severe
  • ChlorphenesinG01AX21severe
  • ProcarbazineL01XB01severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dihydrocodeine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dihydrocodeine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Codidol Retard, Dehace Retard
  • Belgium · Paracodine
  • Bulgaria · Дхц Енноген
  • Czechia · Dhc Ennogen
  • Estonia · Dhc Ennogen
  • Spain · Paracodina, Tosidrin
  • France · Dicodin L.P.
  • United Kingdom (Northern Ireland) · Df118 Forte, Dhc Continus
  • Hungary · Dhc Continus, Hydrocodin
  • Ireland · Paracodin
  • Latvia · Dhc Ennogen
  • Malta · Tosidrin
  • Poland · Dhc Ennogen
  • Romania · Dhc Ennogen
  • Slovakia · Dhc Ennogen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7b18407e-cec3-43b5-bcd0-e8966621efb7
GET /v1/drugs/7b18407e-cec3-43b5-bcd0-e8966621efb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Dihydrocodeine",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about dihydrocodeine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console